The results demonstrated that CDH17-targeting CDH17-CAR-NK92 cells significantly impeded tumor growth and extended mouse survival compared to the C9-CAR-NK92 cells (Fig. 4C and D, Supporting Information Fig. S9). This evidence concerns the gene CDH17 and neoplasm.